News archive
GLP‑1 news from 1959
1 dated, sourced GLP-1 developments from 1959: approvals, trial results, prices, lawsuits, compounding and culture.
- Regulation
Phentermine won FDA approval in 1959 and is still labeled for short-term weight loss
Phentermine received its initial U.S. approval in 1959 as a short-term adjunct to weight loss for adults with a body mass index of 30 or higher, or 27 or higher with conditions such as diabetes or controlled hypertension. It remains a Schedule IV controlled substance that the label describes as chemically and pharmacologically related to amphetamine, with warnings about rare lung and heart problems and loss of effect within a few weeks.